High omega3 fish oil EPA formulation shows a decrease in Major Depressive Disorder when augmenting treatment with Citalopram

High omega3 fish oil EPA formulation shows a decrease in Major Depressive Disorder when augmenting treatment with Citalopram –

TakeOmega3 has 750 mg EPA and 50mg DHA , previous research has shown that low levels of DHA ie 6% is key to successful treatment with regards mental health disorders

Omega 3 Fatty Acid Augment Citalopram for Patients with Major Depressive Disorder

Gertsik L, Poland R, Bresee C, et al.
Omega 3 Fatty Acid Augmentation of Citalopram Treatment for Patients With Major Depressive Disorder. Journal of Clinical Psychopharmacology: February 2012
Objective: The objective of this study was to explore the efficacy of combination therapy with citalopram plus omega 3 fatty acid( sourced from fish oil )fatty acids versus citalopram plus placebo (olive oil) in the initial treatment of individuals with major depressive disorder MDD hypothesized that combination therapy would lead not only to greater efficacy but also to a more rapid onset of therapeutic response.

Methods: Forty-two subjects participated in this 9-week randomized, masked, placebo-controlled study of combination therapy 900 mg of eicosapentaenoic acid, 200 mg of and docosahexaenoic acid, and 100 mg of other omega-3 fatty acids per two capsules administered twice daily plus citalopram) versus monotherapy (two 1 g capsules of olive oil per day plus citalopram) treatment of MDD. 4 capsules of omega3 in total was taken daily

Results: The combination therapy demonstrated significantly greater improvement in Hamilton Depression Rating scale scores over time (F = 7.32; df 1,177; P = 0.008) beginning at week 4 (t = −2.48; df 177; P = 0.014).

Conclusions: Combination therapy was more effective than monotherapy in decreasing signs and symptoms of MDD during the 8 weeks of active treatment; however, combination therapy did not seem to enhance the speed of the initial antidepressant response. These findings suggest that there may be an advantage to combining omega-3 fatty acids with a selective serotonin uptake inhibitor in the initial treatment of individuals with MDD. A larger definitive study is warranted

Related posts:

  1. Omega-3 fatty acids for major depressive disorder associated with the menopausal transition: a preliminary open trial.
  2. Omega3 fish oil EPA as effective as Prozac in the treatment of medium to major depression
  3. Research shows effectiveness of a daily dose 2.5G omega3 re treatment of depression in elderly
  4. Omega-3 high EPA formulation Effective for Treating Child ADHD
  5. Low plasma levels of Omega3 essential fatty acid EPA are associated with bipolar disorder

Tags: , ,

Leave a Reply

Great Britain Flag
Made in the UK - Take Omega 3 Suspendisse lacinia ultricies justo, at ultricies nisi tempus ac. Cras sed vehicula metus. Phasellus...